{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:28:43Z","timestamp":1740137323993,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10238-021-00696-x","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T09:04:51Z","timestamp":1615194291000},"page":"493-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An enigmatic case of IgG4-related nephropathy and an updated review of the literature"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-4776","authenticated-orcid":false,"given":"Leonardo","family":"Spatola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Sghirlanzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Verdesca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Menegotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuisa","family":"Querques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Livio","family":"Camozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriana","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico Eugenio","family":"Minetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"issue":"10","key":"696_CR1","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64(10):3061\u20137. https:\/\/doi.org\/10.1002\/art.34593.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"696_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/apm.12845","volume":"126","author":"JR Bledsoe","year":"2018","unstructured":"Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS. 2018;126(6):459\u201376. https:\/\/doi.org\/10.1111\/apm.12845.","journal-title":"APMIS"},{"issue":"4","key":"696_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/j.semdp.2012.07.006","volume":"29","author":"V Deshpande","year":"2012","unstructured":"Deshpande V. IgG4-related disease. Introduction Semin Diagn Pathol. 2012;29(4):175\u20136. https:\/\/doi.org\/10.1053\/j.semdp.2012.07.006.","journal-title":"Introduction Semin Diagn Pathol"},{"key":"696_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/BF02232341","volume":"6","author":"H Sarles","year":"1961","unstructured":"Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas\u2013an autonomous pancreatic disease? Am J Dig Dis. 1961;6:688\u201398.","journal-title":"Am J Dig Dis"},{"issue":"2","key":"696_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2559.2005.02204.x","volume":"47","author":"S Aoki","year":"2005","unstructured":"Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients\u2019 sera. Histopathology. 2005;47(2):147\u201358.","journal-title":"Histopathology"},{"issue":"9","key":"696_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.5858\/2005-129-1148-APMTJA","volume":"129","author":"V Deshpande","year":"2005","unstructured":"Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Arch Pathol Lab Med. 2005;129(9):1148\u201354.","journal-title":"Arch Pathol Lab Med."},{"issue":"5","key":"696_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1751-2980.2012.00583.x","volume":"13","author":"H Igarashi","year":"2012","unstructured":"Igarashi H, Ito T, Oono T, Nakamura T, et al. Relationship between pancreatic and\/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4-related diseases. J Dig Dis. 2012;13(5):274\u20139. https:\/\/doi.org\/10.1111\/j.1751-2980.2012.00583.x.","journal-title":"J Dig Dis."},{"issue":"7","key":"696_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.2011010062","volume":"22","author":"Y Raissian","year":"2011","unstructured":"Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22(7):1343\u201352. https:\/\/doi.org\/10.1681\/ASN.2011010062.","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"696_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ki.2010.271","volume":"78","author":"T Saeki","year":"2010","unstructured":"Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitialnephritis. Kidney Int. 2010;78(10):1016\u201323. https:\/\/doi.org\/10.1038\/ki.2010.271.","journal-title":"Kidney Int."},{"issue":"10","key":"696_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrneph.2015.95","volume":"11","author":"FB Cortazar","year":"2015","unstructured":"Cortazar FB, Stone JH. IgG4-related disease and the kidney. Nat Rev Nephrol. 2015;11(10):599\u2013609. https:\/\/doi.org\/10.1038\/nrneph.2015.95.","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"696_CR11","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.prp.2015.03.004","volume":"211","author":"D Pradhan","year":"2015","unstructured":"Pradhan D, Pattnaik N, Silowash R, Mohanty SK. IgG4-related kidney disease\u2013A review. Pathol Res Pract. 2015;211(10):707\u201311. https:\/\/doi.org\/10.1016\/j.prp.2015.03.004.","journal-title":"Pathol Res Pract."},{"issue":"2","key":"696_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/j.ackd.2016.12.001","volume":"24","author":"P Zhang","year":"2017","unstructured":"Zhang P, Cornell LD. IgG4-related tubulointerstitial nephritis. Adv Chronic Kidney Dis. 2017;24(2):94\u2013100. https:\/\/doi.org\/10.1053\/j.ackd.2016.12.001.","journal-title":"Adv Chronic Kidney Dis."},{"issue":"9","key":"696_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392. https:\/\/doi.org\/10.1038\/modpathol.2012.72.","journal-title":"Mod Pathol."},{"issue":"19","key":"696_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5527\/wjn.v7.i1.29","volume":"7","author":"M Salvadori","year":"2018","unstructured":"Salvadori M, Tsalouchos A. Immunoglobulin G4-related kidney diseases: an updated review. Word J Nephrol. 2018;7(19):29\u201340.","journal-title":"Word J Nephrol."},{"key":"696_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.humpath.2016.05.010","volume":"55","author":"S Hara","year":"2016","unstructured":"Hara S, Kawano M, Mizushima I, et al. Distribution and components of interstitial inflammation and fibrosis in IgG4-related kidney disease: analysis of autopsy specimens. Hum Pathol. 2016;55:164\u201373. https:\/\/doi.org\/10.1016\/j.humpath.2016.05.010.","journal-title":"Hum Pathol."},{"key":"696_CR16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011010062","author":"Y Raissian","year":"2011","unstructured":"Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011. https:\/\/doi.org\/10.1681\/ASN.2011010062.","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"696_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MNH.0000000000000102","volume":"24","author":"M Kawano","year":"2015","unstructured":"Kawano M, Saeki T. IgG4-related kidney disease\u2013an update. Curr Op in Nephrol Hypertens. 2015;24(2):193\u2013201. https:\/\/doi.org\/10.1097\/MNH.0000000000000102.","journal-title":"Curr Op in Nephrol Hypertens"},{"issue":"9506","key":"696_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241\u201351.","journal-title":"Lancet"},{"issue":"4","key":"696_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40620-016-0279-4","volume":"29","author":"G Quattrocchio","year":"2016","unstructured":"Quattrocchio G, Roccatello D. IgG4-related nephropathy. J Nephrol. 2016;29(4):487\u201393. https:\/\/doi.org\/10.1007\/s40620-016-0279-4.","journal-title":"J Nephrol"},{"issue":"9","key":"696_CR20","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67(9):2466\u201375. https:\/\/doi.org\/10.1002\/art.39205.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"696_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","volume":"15","author":"M Kawano","year":"2011","unstructured":"Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(5):615\u201326. https:\/\/doi.org\/10.1007\/s10157-011-0521-2.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"696_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ejrad.2014.03.033","volume":"83","author":"B Kim","year":"2014","unstructured":"Kim B, Kim JH, Byun JH, et al. IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusion-weighted imaging. Eur J Radiol. 2014;83(7):1057\u201362. https:\/\/doi.org\/10.1016\/j.ejrad.2014.03.033.","journal-title":"Eur J Radiol"},{"issue":"6","key":"696_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539\u201351. https:\/\/doi.org\/10.1056\/NEJMra1104650.","journal-title":"N Engl J Med"},{"key":"696_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/82_2016_36","volume":"401","author":"T Kamisawa","year":"2017","unstructured":"Kamisawa T, Okazaki K. Diagnosis and Treatment of IgG4-Related Disease. Curr Top Microbiol Immunol. 2017;401:19\u201333. https:\/\/doi.org\/10.1007\/82_2016_36.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"696_CR25","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS. Crowe JL et al International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67(7):1688\u201399. https:\/\/doi.org\/10.1002\/art.39132.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"696_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3960\/jslrt.54.95","volume":"54","author":"Y Masaki","year":"2014","unstructured":"Masaki Y, Shimizu H, Sato Nakamura T, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop. 2014;54(2):95\u2013101.","journal-title":"J Clin Exp Hematop"},{"key":"696_CR27","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gut.2008.172908","volume":"58","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504\u20137.","journal-title":"Gut"},{"key":"696_CR28","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1136\/gut.2007.129833","volume":"56","author":"A Ghazale","year":"2007","unstructured":"Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut. 2007;56:1650\u20132.","journal-title":"Gut"},{"key":"696_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706\u201315.","journal-title":"Gastroenterology"},{"key":"696_CR30","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/ajg.2009.325","volume":"104","author":"A Raina","year":"2009","unstructured":"Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295\u2013306.","journal-title":"Am J Gastroenterol"},{"key":"696_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00535-014-0945-z","volume":"49","author":"T Kamisawa","year":"2014","unstructured":"Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013. III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961\u201370.","journal-title":"J Gastroenterol"},{"issue":"6","key":"696_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10165-011-0589-2","volume":"22","author":"I Mizushima","year":"2012","unstructured":"Mizushima I, Yamada K, Fujii H, et al. Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis. Mod Rheumatol. 2012;22(6):859\u201370. https:\/\/doi.org\/10.1007\/s10165-011-0589-2.","journal-title":"Mod Rheumatol."},{"issue":"3","key":"696_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ndtplus\/sfp023","volume":"2","author":"N Mise","year":"2009","unstructured":"Mise N, Tomizawa Y, Fujii A, Yamaguchi Y, Sugimoto T. A case of tubulointerstitial nephritis in IgG4-related systemic disease with markedly enlarged kidneys. NDT Plus. 2009;2(3):233\u20135. https:\/\/doi.org\/10.1093\/ndtplus\/sfp023.","journal-title":"NDT Plus"},{"issue":"6","key":"696_CR34","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74(6):1171\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206605.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"696_CR35","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1136\/annrheumdis-2015-207625","volume":"74","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M, Awakawa T, Takahashi H. Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years. Ann Rheum Dis. 2015;74(8):e46.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"696_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012;91(1):57\u201366. https:\/\/doi.org\/10.1097\/MD.0b013e3182431ef6.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"696_CR37","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/ndt\/gfr109","volume":"26","author":"D Roccatello","year":"2011","unstructured":"Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy. Nephrol Dial Transplant. 2011;26(12):3987\u201392. https:\/\/doi.org\/10.1093\/ndt\/gfr109.","journal-title":"Nephrol Dial Transplant"},{"key":"696_CR38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62:1607\u201315.","journal-title":"Gut"},{"key":"696_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients with IgG4-related disease. Medicine (Baltimore). 2012;91:57\u201366.","journal-title":"Medicine (Baltimore)"},{"key":"696_CR40","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1210\/jc.2012-4050","volume":"98","author":"SB Soh","year":"2013","unstructured":"Soh SB, Pham A, O\u2019Hehir RE, et al. Novel use of rituximab in a case of Riedel\u2019s thyroiditis refractory to glucocorticoids and tamoxifen. J Clin Endocrinol Metab. 2013;98:3543\u20139.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00696-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00696-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T14:15:14Z","timestamp":1625753714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00696-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["696"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00696-x","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"type":"print","value":"1591-8890"},{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patient has consented to the submission of the case report to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Approved by the Local Ethical Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}